SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: CYBERKEN who wrote (21358)5/24/1998 4:55:00 PM
From: jayhawk969  Read Replies (1) | Respond to of 32384
 
If I read it correctly there is a bonus in owning SRGN vs owning LGND provided that ONTAK is approved on June 2. The bonus amounts to a 46% premium paid six months later subject to the drugs approval. The only cost is the percentage charged for commissions to acquire SGRN due to its low share price.

Do you see this the same way?